Featured Clinical Studies

Featured Clinical Studies Program

The American Brain Tumor Association (ABTA) Featured Clinical Studies Program aims to provide patients and caregivers a way to easily understand and navigate to available clinical trials and other types of patient studies (i.e. registries, surveys) to increase patient consideration and participation.

The ABTA Featured Clinical Studies Program allows medical centers and companies to pay to have their clinical study featured on the ABTA website. All clinical studies listed have been reviewed by an Institutional Review Board, as required by the U.S. Food and Drug Administration. Each study also undergoes an intensive review by ABTA staff and a clinical review committee. These listings are sponsored, and do not imply ABTA endorsement or preference. The clinical studies featured, include clinical trials as well as other studies such as registries and observational studies.

The clinical studies listed below do not include all brain tumor clinical studies currently recruiting patients within the U.S. To access the most comprehensive list of available clinical trials, visit ClinicalTrials.gov.

Find A Featured Clinical Study

To find a featured clinical study that may be an option for you, simply select your tumor type and location preference. Our listing of featured clinical studies is updated monthly.

If your tumor type is not available, visit ClinicalTrials.gov and talk with your doctor.

  • Select Tumor Type(s)

  • Select State(s)

Search Results:

A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided Focused Ultrasound in Patients With Recurrent or Progressive Glioblastoma Multiforme

Category (Adult, Pediatric): Adult
Phase: 1/2
Description: The primary goal of this trial is to evaluate the safety and preliminary efficacy of sonodynamic therapy (SDT) using intravenous SONALA-001 combined with Exablate Type-2 MRI-guided focused ultrasound in patients with recurrent or progressive glioblastoma.
Learn More »

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Category (Adult, Pediatric): Adult
Phase: 2
Description: This study will evaluate tirabrutinib treatment in patients with Primary Central Nervous System Lymphoma (PCNSL).
Learn More »

Not finding what you are looking for?

To access a comprehensive list of clinical trials visit ClinicalTrials.gov or speak with your Doctor.